Yongin Severance Hospital
Yongin-si, Gyeonggi-do, 16995, South Korea
Location status: Recruiting
Location contact
Na Young Kim
CONTACT
Na Young Kim, MD, PhD
PRINCIPAL_INVESTIGATOR
Seung Ick Choi
CONTACT
NCT Number: NCT06442982
The goal of this clinical trial is to explore the usefulness of information from insole-type gait analyzer in adults with subjective gait and balance disorders.
The main questions it aims to answer are:
How useful is an insole-type gait analyzer for collecting gait data from patients with gait disturbances?
Researchers will explore the usefulness of collected data and does not establish a control group.
Participants will:
Participants will conduct survey and perform the Timed up and go test wearing an insole-type gait analyzer.
Interested in participating?
Request Info19 year and older
All sexes
Interventional
Not applicable
Yongin-si, Gyeonggi-do, 16995, South Korea
Location status: Recruiting
Na Young Kim
CONTACT
Na Young Kim, MD, PhD
PRINCIPAL_INVESTIGATOR
Seung Ick Choi
CONTACT
A screening test is conducted after obtaining consent. The screening test assesses whether participants can walk independently on flat ground, following an inquiry into their baseline symptoms and signs.
Participants will conduct A history survey, a sarcopenia questionnaire, and the International Physical Activity Questionnaire (IPAQ).
Participants will wear insole-type gait analyzer and undergo the Timed Up and Go test.
The measurement values of the accelerometer and pressure sensors recorded in the insole-type gait analyzer will be examined to determine the presence of missing or outlier data. Researchers will explore the data collection frequency and analysis methods to extract clinically significant data.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients with subjective gait and balance disorders will wear insole-type gait analyzer and walk, then the collected data will be examined.
Time frame: TUG test session will last approximately 5 minutes. and TUG test will be performed at baseline.
The participants will wear insole-type gait analyzer and undergo the Timed Up and Go test.
The above test assesses walking speed along with balance ability during walking, and this is performed as follows.
Time frame: This K-SSQ session will last approximately 1 minutes, it will be performed at baseline.
Questionnaire that evaluates the decrease in muscle strength and functional performance along with a decrease in muscle mass and it is highly related to aging and chronic diseases. The evaluation method is conducted by having the examiner ask the subject about the following questionnaire, and the scores for the answers are recorded.
It consists of 5 questions, and each question is scored 0-2 points. The higher the score, the higher the risk of sarcopenia. If the score is 4 or higher, sarcopenia may be suspected.
Time frame: This K-IPAQ session will last approximately 3 minutes, it will be performed at baseline.
Tests that assess various aspects of an individual's daily physical activity16 and it can provide information about activity level. The examiner questions the subject based on the questionnaire below, records related information, calculates the total activity time and intensity, and classifies it as 'low', 'medium', and 'high'.
Contact information is provided by the study sponsor or research team.
Na Young Kim, MD, PhD
CONTACT
Seung Ick Choi
CONTACT
Yonsei University
Other
Usefulness of Insole-type Gait Analyzer in Collecting Gait Data From Patients With Gait Disturbance
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04460872
Androgen Deficiency, Bone Diseases
Gainesville, Florida, United States
View Trial DetailsNCT04934085
Activity, Motor, Balance; Distorted
Rzeszów, Podkarpackie Voivodeship, Poland
View Trial DetailsNCT05417399
Brain Damage, Chronic, Brain Diseases
Enschede, Overijssel, Netherlands
View Trial DetailsNCT07630311
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Ioannina, Greece
View Trial Details